Messenger RNA (mRNA) molecules lead precarious lives. After being synthesized as precursors, eukaryotic mRNAs run the risk of degradation, both before and after a series of regulated processing steps. The probability of degradation is determined by various RNA-interacting factors, which together with the mRNA form a complex called the messenger ribonucleoprotein (mRNP). The composition of this mRNP ultimately dictates the half-life of a given mRNA.
The rate of mRNA decay is also influenced by translation. For example, recognition of a premature termination (nonsense) codon by the translation machinery typically accelerates mRNA decay (Figure 1, right panel) . This nonsense-mediated decay (NMD) response is physiologically important, because nonsense codons lead to the generation of truncated proteins that are potentially toxic to the cell.
The rate of mRNA translation is also under regulatory control. Included in the cell's tool bag of translational regulatory factors are microRNAs (miRNAs), which are ?22 nucleotide RNAs that bind by base complementarity to the 3′ untranslated region (UTR) of most of their targets ( Figure 1, left panel) . miRNAs usually act in a negative manner, repressing the translation of their mRNA targets or triggering their decay. By analogy with most transcription factors, miRNAs act on a wide range of targets in a combinatorial manner.
Thus, a single miRNA can repress the translation of many mRNA targets-sometimes over 100-and a single mRNA may be regulated by many miRNAs. Current estimates suggest that an astounding onethird of mammalian mRNAs are subject to miRNA-mediated translational repression (Pillai, 2005) .
Where do translational repression and mRNA decay occur? Do these events occur at random or at specific sites in the cytoplasm? Although a complete answer has not yet emerged, recent evidence, including findings in two papers in this issue (Bhattacharyya et al., 2006; Sheth and Parker, 2006) , suggests that a significant fraction of these posttranscriptional events occur in a cytoplasmic compartment called a P-body (or GW body). P-bodies are dynamic structures discovered 3 years ago that contain high concentrations of molecules involved in mRNA decay and translational repression (Liu et al., 2005) . Strong evidence that P-bodies are sites of normal mRNA decay rather than merely storage sites for RNA decay factors is that they accumulate mRNA decay intermediates. Also, blocking mRNA decay events, such as decapping and exoribonuclease cleavage, results in larger and more abundant P-bodies.
Conversely, blocking deadenylation of mRNAs reduces the size and number of P-bodies, suggesting that poly (A) shortening is linked to their assembly or integrity. P-bodies are also probably sites of translational repression, as translationally arrested mRNAs accumulate in P-bodies, whereas ribosomal proteins and some translation factors are largely absent from P-bodies. Furthermore, inhibitors of translational initiation increase the number and size of P-bodies, whereas inhibitors of translational elongation (which trap ribosomes on mRNAs) have the opposite effect. Several lines of evidence suggest that miRNA-mediated translational repression occurs in P-bodies, including the finding that miRNA-repressed mRNAs localize to P-bodies and that silencing of GW182, a structural component of Pbodies, leads to loss of P-bodies and impairment of miRNA function (Liu et al., 2005) . Bhattacharyya et al. (2006) asked whether an mRNA that is translationally repressed can escape the clutches of a P-body. As an experimental model, these authors examined the mRNA encoding the cationic amino-acid transporter 1 (CAT-1), which contains a 3′UTR that is negatively regulated by the miRNA miR-122 (Chang et al., 2006) . The authors discovered that translationally repressed CAT-1 mRNA is localized in P-bodies. However, it can escape translational repression and P-body entrapment in response to amino acid starvation, oxidative stress, or endoplasmic reticulum stress ( Figure 1 , left panel). Interestingly, both translational derepression
P-Bodies React to Stress and Nonsense
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and P-body exit require AU-rich elements (AREs), which are present in the CAT-1 3′ UTR. These elements bind to HuR, an ARE binding protein (ARE-BP) of the ELAV family ( Figure  1 , left panel). The authors found that HuR is necessary to release reporter mRNAs from miRNA-mediated translational blockade and P-body entrapment.
The work of Bhattacharyya et al. (2006) provides strong evidence that mammalian P-bodies are not a terminal end-point for mRNAs, on the contrary, an mRNA in a P-body can return to the actively translated pool of mRNAs if an appropriate stimulus is received (Figure 1 ). But what constitutes an appropriate stimulus? Which stresses elicit the response and which do not? What about nonstress stimuli, such as growth signals or developmental cues? And do sequences other than those found in 3′UTRs have a role in the response? On that note, sequences in the 5′UTR of CAT-1 have been reported to derepress translation in response to amino acid starvation in cells that do not express miR-122 (Yaman et al., 2003) . It is also unclear whether derepression of translation is a general response to stress that extends to transcripts other than CAT-1 and to nonmammalian cells. Clearly, some proteins exhibit the opposite response and show decreased expression in response to stress, which explains why various forms of stress (including glucose deprivation, osmotic stress, ultraviolet light, and late-stage growth) are known to repress translation and increase the number of P-bodies in yeast.
Another intriguing aspect of CAT-1 regulation is that the ARE-BP HuR participates in the derepression of CAT-1 translation and its movement out of P-bodies. Does HuR repel the miRNA complex that represses translation, or does it somehow block the complex from acting? HuR is relatively unique among ARE-BPs in that it typically promotes mRNA stability and translation, whereas most AREBPs usually have a negative effect on gene expression (Barreau et al., 2005) . These other ARE-BPs may collaborate with miRNAs to decrease gene expression. A recently discovered example is tristetraprolin, which acts with miR-16 to efficiently elicit the decay of the mRNA encoding the cytokine tumor necrosis factor-α (Jing et al., 2005) . HuR, in contrast, may mediate its positive effects on the expression of its wide range of mRNA targets by interfering with the function of miRNAs. (2006) provide evidence that the miRNA miR-122 represses the translation of the cationic amino acid transporter-1 (CAT-1) mRNA in P-bodies. Stress relieves this repression, releasing CAT-1 mRNA from P-bodies and allowing its active translation. The derepression of CAT-1 translation requires HuR, an RNA binding protein that interacts with AU-rich elements (AREs) in the 3′UTR of CAT-1. Because HuR is a nuclear-cytoplasmic shuttling protein it may be recruited to CAT-1 mRNA when it is first made in the nucleus. Alternatively, HuR may be recruited to CAT-1 mRNA in the cytoplasm in response to stress, as some stresses are known to mobilize HuR to the cytoplasm. 7mG is a specialized 5′ cap found on mRNAs, and AAA represents the polyadenosine tail found on most mRNAs. (Right) According to Sheth and Parker (2006) , P-bodies are sites where aberrant mRNAs harboring premature termination (nonsense) codons are degraded by an RNA surveillance pathway called nonsense-mediated decay (NMD). Recruitment of PTC-bearing mRNAs to P-bodies requires UPF1, an ATPase-dependent RNA helicase essential for NMD. Entry into the P-body is not sufficient for mRNA decay; also required is UPF1 ATP hydrolysis and ill-defined steps mediated by the NMD proteins UPF2 and UPF3. Some normal mRNAs are also present in P-bodies, where they may be stored as translationally repressed mRNAs. Normal mRNAs can also exit P-bodies to be translated, a process that evidence from Sheth and Parker (2006) indicates requires UPF1-mediated ATP hydrolysis. Sheth and Parker (2006) focused their study on the role of P-bodies in mRNA decay. In particular, they addressed whether P-bodies are compartments in which aberrant transcripts harboring nonsense codons are degraded by the NMD pathway. They obtained several lines of evidence that the answer is yes, at least in yeast (Figure 1, right panel) . First, they found that nonsense codon-bearing reporter transcripts are localized to P-bodies. Second, this localization requires Upf1p, an RNA helicase essential for NMD. Third, Upf1p and two other NMD proteins, Upf2p and Upf3p, accumulate in P-bodies when the catalytic step of NMD is blocked. Fourth, Upf protein accumulation appears to be specific for the NMD pathway, as it did not occur in a mutant yeast strain deficient in normal mRNA decapping. Finally, inhibition of NMD triggered an increase in the size and number of P-bodies.
Intriguingly, Sheth and Parker (2006) obtained evidence that Upf1p has at least two distinct functions: it promotes mRNA entry into a Pbody, and together with Upf2p and Upf3p, it is necessary for the decay of the target mRNA once entrapped in the P-body (Figure 1, right panel) . The use of an ATPase defective form of Upf1p was key to determining the second function of this protein.
Forced expression of mutant Upf1p increased the size and number of Pbodies, suggesting that ATP hydrolysis by Upf1p is required for the degradation of nonsense codon-bearing transcripts in P-bodies. Remarkably, the ATPase-defective Upf1p mutant also dramatically increased the level of normal transcripts in Pbodies. This suggested that normal transcripts enter P-bodies and that Upf1p ATPase hydrolysis is required for them to escape.
The findings of Sheth and Parker (2006) led them to propose a model in which two rounds of discrimination dictate whether a transcript is targeted for decay in P-bodies. The first round determines whether an mRNA enters into a P-body, and the second round determines whether it is degraded there. This two-round system might significantly increase the fidelity of RNA surveillance, thus ensuring that more of the aberrant transcripts are degraded and more of the normal transcripts are spared. Currently, it is not known how Upf1p directs the formation of yeast P-bodies: does it promote the entry of mRNAs into existing P-bodies, or does it favor the aggregation of mRNAs such that they form new P-bodies? Also unclear is the part played by ATPase hydrolysis in UPF1's second role promoting the degradation of aberrant transcripts once they are in P-bodies. In mammalian cells, UPF1-mediated ATP hydrolysis appears to also be involved in the later stages of NMD, as UPF1 mutants lacking the ATPase domain are still able to interact with the NMD proteins UPF2 and UPF3 (Kashima et al., 2006) . This ATP hydrolysis step might trigger mRNA decay by altering the molecular conformation of the mRNP complex, enabling attack by ribonucleases.
Several other issues about Pbodies remain unresolved. The factors that determine whether a given mRNA accumulates in a P-body are not understood. Which proteins in the mRNP dictate this decision, and how do they interact with the miRNAs that apparently destine mRNAs for P-bodies? What determines whether an mRNA is stored or degraded in a P-body? Does translational repression occur before or after P-body formation? Can only mRNAs that retain their 5′ cap and most of their polyadenosine tail leave P-bodies and resume translation? The answers to these questions will require using techniques to follow the fate of a population of mRNAs over time. What proportion of RNA decay and translational repression occurs in P-bodies? Clearly, some mRNA decay occurs elsewhere, because the exosome, which mediates 3′-to-5′ decay of mRNA, is not in P-bodies. Useful tools to address these questions would include specific markers of both mRNA decay and translation in living cells to detect decay intermediates and peptidyl-tRNAs, respectively. Finally, are the functions and responses of P-bodies conserved across phyla? Like mammalian P-bodies, yeast Pbodies can be nudged into releasing their mRNAs so that they can return to the translation pool (Brengues et al., 2005) . NMD components are found in mammalian P-bodies suggesting that, as in yeast, mammalian NMD occurs in P-bodies. It remains to be seen whether the mechanisms for translational derepression and NMD in P-bodies are conserved in different organisms.
In Shakespeare's Macbeth, a series of murders prophesized by witches lead the anguished Lady Macbeth to exclaim, "What's done cannot be undone." Likewise, once it is defined as aberrant, an mRNA harboring a premature termination codon is apparently fated to die in Pbodies. In contrast, normal mRNAs do not necessarily suffer the same fate, but rather, like Lazarus, they can escape the P-body tomb to resume translation.
